Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Archives of Disease in Childhood|September 4, 2012
Developing a new formulation of sodium phenylbutyrateNathalie Guffon, Yves Kibleur, William Copalu, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 28, 2006
Saturable binding of indisulam to plasma proteins and distribution to human erythrocytesAnthe S Zandvliet, William Copalu, Jan H M Schellens, et al.Journal of Pharmacokinetics and Pharmacodynamics|February 10, 2009
Covariate-based dose individualization of the cytotoxic drug indisulam to reduce the risk of severe myelosuppressionAnthe S Zandvliet, Jan H M Schellens, William Copalu, et al.Journal of Pharmacokinetics and Pharmacodynamics|September 2, 2006
A semi-physiological population pharmacokinetic model describing the non-linear disposition of indisulamAnthe S Zandvliet, Jan H M Schellens, William Copalu, et al.Investigational New Drugs|February 10, 2009
Two-stage model-based clinical trial design to optimize phase I development of novel anticancer agentsAnthe S Zandvliet, Mats O Karlsson, Jan H M Schellens, et al.CPT: Pharmacometrics & Systems Pharmacology|September 12, 2019
Population Pharmacokinetic Analysis for Imipenem-Relebactam in Healthy Volunteers and Patients With Bacterial InfectionsPratik Bhagunde, Parul Patel, Mallika Lala, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2007
CYP2C9 and CYP2C19 polymorphic forms are related to increased indisulam exposure and higher risk of severe hematologic toxicityAnthe S Zandvliet, Alwin D R Huitema, William Copalu, et al.Clinical and Translational Science|October 27, 2021
Population pharmacokinetic/pharmacodynamic assessment of imipenem/cilastatin/relebactam in patients with hospital-acquired/ventilator-associated bacterial pneumoniaMunjal Patel, Francesco Bellanti, Naveen M Daryani, et al.British Journal of Clinical Pharmacology|July 19, 2012
Pharmacokinetics of eribulin mesylate in patients with solid tumours receiving repeated oral rifampicinLot A Devriese, Petronella Els O Witteveen, Jantien Wanders, et al.Pageof 1